Skip navigation

Custom Microsite CSS rev: 2018.02.15

Enhance Process and System Interoperability to Optimize Data Quality, Improve Trial Efficiency and Ensure Protection of Human Subjects

November 8-9, 2018
  • Philadelphia, PA

CBI’s Risk-Based Trial Management and Monitoring conference is dedicated to reducing the complexity of implementing an efficient RBM methodology and providing real-world strategies to system adoption and process integration.

The concept of RBM is nothing new, however many questions still remain around successfully achieving implementation: Are we making it more complex than it needs to be? How can we work more effectively with sites and other stakeholders? How can we demystify and implement complex RBM models in a straightforward manner? And now, with each organization collecting clinical data across multiple systems, usually in their own format and reporting environments, the integration of data has become increasingly difficult.

Join your peers, RBM thought-leaders and trial counterparts in November to collaborate on effective processes of developing and implementing a risk based plan while adhering to regulatory expecations.

WHAT’S NEW IN 2018?

  • Examine the ICH E6 guidelines and how it affects
    RBM and centralized monitoring
  • Gain critical insights into regulatory expectations of
    RBM trials versus other clinical trials
  • Methodologies for adaptive trial management
  • How to effectively develop and execute a risk-based plan
  • Best practices for integrating RBM into site processes
  • Address common challenges around site staff adoptions

Previous Attendee Acclaim:

My company is just starting to implement RBM.
This conference helped me understand A-Z all the
details that will be needed – exciting!

Senior CRA, Regeneron

The ideal forum to be on the forefront of emerging strategies and approaches to clinical trial oversight.

Manager, Clinical Monitoring, St. Jude Medical

Great conference – nice broad array of attendees from different side of the business – gives good perspective.

Information Strategist, Pfizer

This conference was a great way to get the pulse of RBM across the industry and prepare for the next steps as it evolves.

Associate Director, Clinical Innovation, INC Research